## Biocon Limited (BIOCON) Stock Analysis - December 20, 2024

This report analyzes Biocon Limited's stock performance and provides a buy, sell, or hold recommendation based solely on the provided data.

**1. Data Preprocessing:**

The provided data has been parsed and organized into the following sections:

**1.1 Company Profile:**

| Feature          | Value                     |
|-----------------|--------------------------|
| Symbol           | BIOCON                    |
| Company Name     | Biocon Limited            |
| Industry         | Pharmaceuticals           |
| Listing Date     | April 7, 2004             |
| ISIN             | INE376G01013              |


**1.2 Market Data:**

| Metric                | Value      |
|-----------------------|------------|
| Last Price            | ₹336.00    |
| Change                | ₹-14.35    |
| % Change              | -4.10%     |
| Previous Close        | ₹350.35    |
| Open                  | ₹350.00    |
| Close                 | ₹335.95    |
| VWAP                  | ₹340.48    |
| Week High             | ₹395.80    |
| Week Low              | ₹239.30    |
| Sector PE             | 22.95      |
| Symbol PE             | 22.23      |
| Total Traded Volume   | 2,889,197  |
| Delivery Quantity     | 1,301,339  |
| Delivery %            | 45.04%     |
| CM Daily Volatility   | 2.17       |
| CM Annual Volatility  | 41.46      |


**1.3 Corporate Actions:**

| Ex-Date      | Purpose                               |
|--------------|---------------------------------------|
| July 5, 2024  | Dividend - ₹0.50 Per Share            |
| July 7, 2023  | Dividend - ₹1.50 Per Share            |
| June 30, 2022 | Dividend - ₹0.50 Per Share            |
| July 18, 2019 | Dividend - ₹0.50 Per Share            |
| June 12, 2019 | Bonus 1:1                             |
| July 19, 2018 | Dividend - ₹1.00 Per Share            |
| July 20, 2017 | Dividend - ₹1.00 Per Share            |
| June 15, 2017 | Bonus 2:1                             |


**1.4 Recent Announcements:** (Last 7 days)

* December 18, 2024: Analysts/Institutional Investor Meet/Con. Call Updates
* December 17, 2024: Analysts/Institutional Investor Meet/Con. Call Updates
* December 15, 2024: Updates
* December 14, 2024: Updates
* December 11, 2024: Analysts/Institutional Investor Meet/Con. Call Updates
* December 11, 2024: Press Release
* December 10, 2024: Sale or disposal-XBRL
* December 10, 2024: General Updates


**1.5 Financial Results (Last Five Quarters):**

| Quarter End    | Income (₹) | Expenditure (₹) | Profit After Tax (₹) | EPS (₹) |
|----------------|-------------|-----------------|----------------------|---------|
| Sep 30, 2024   | 59,890      | 57,800           | 320                   | 0.03    |
| Jun 30, 2024   | 55,250      | 55,140           | 90                    | 0.01    |
| Mar 31, 2024   | 57,150      | 54,970           | 1,400                 | 0.12    |
| Dec 31, 2023   | 61,130      | 57,840           | 2,400                 | 0.20    |
| Sep 30, 2023   | 58,830      | 53,710           | 3,470                 | 0.29    |


**1.6 Shareholding Patterns:**

Promoter holding has remained consistently at 60.64% over the last five quarters. Public shareholding has slightly increased from 38.97% to 39.12% over the same period.


**1.7 Board Meetings:**

Recent board meetings focused on approving financial results and other business matters.


**1.8 Key Management Personnel:**

(List of directors and their designations is available in the provided data but omitted here for brevity.  This information is readily accessible in the original data.)


**2. Key Indicators:**

**2.1 Current Price Analysis:**

* The current price (₹336.00) is significantly lower than the previous close (₹350.35), indicating a downward trend.
* It's also below the week's high (₹395.80) and above the week's low (₹239.30).
* Pre-open activity showed a slight downward trend, with the final pre-open price at ₹350.00.


**2.2 Financial Performance:**

* Revenue shows some fluctuation but generally positive growth over the last five quarters.
* Profitability is inconsistent, with some quarters showing losses and others showing profits.
* EPS is also volatile, reflecting the inconsistent profitability.


**2.3 Shareholding Analysis:**

* Promoter holding remains stable, indicating confidence in the company's future.
* A slight increase in public shareholding might indicate increased investor interest, but this is minor.


**2.4 Corporate Action Summary:**

* Regular dividend payments indicate a commitment to shareholder returns.


**2.5 Volatility and Risk:**

* High annual volatility (41.46%) suggests the stock is relatively risky.


**3. Final Verdict:**

**Hold.**

**Reasoning:**

While the recent price drop is concerning, the consistent promoter holding and regular dividend payments suggest underlying strength.  However, the volatile financial performance and high volatility make a "Buy" recommendation premature.  Further analysis is needed to determine if the recent price drop is a temporary correction or the start of a longer-term decline.  The inconsistent profitability and high volatility present significant risk.  A "Hold" allows for further observation before making a more decisive investment decision.

**Conclusion:**

Biocon Limited shows mixed signals.  While some positive indicators exist (promoter confidence, dividend payments), the inconsistent financial performance and high volatility warrant caution.  More data and analysis are needed to assess the long-term prospects of the company and its stock.  Investors should carefully consider their risk tolerance before investing in BIOCON.
